These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 11332334

  • 21. The efficacy and tolerability of candesartan cilexetil in an elderly hypertensive population.
    McInnes GT, O'Kane KP, Jonker J, Roth J.
    J Hum Hypertens; 1997 Sep; 11 Suppl 2():S75-80. PubMed ID: 9331015
    [Abstract] [Full Text] [Related]

  • 22. Antihypertensive treatment in elderly patients aged 75 years or over: a 24-week study of the tolerability of candesartan cilexetil in relation to hydrochlorothiazide.
    Neldam S, Forsén B, Multicentre Study Group.
    Drugs Aging; 2001 Sep; 18(3):225-32. PubMed ID: 11302289
    [Abstract] [Full Text] [Related]

  • 23. Switch from ABCD pretreatment to A-II-A treatment: a multinational, open, centrally randomized, prospective parallel group comparison.
    Asmar R, Porcellati C, Dusing R.
    Drugs Exp Clin Res; 2004 Sep; 30(4):153-61. PubMed ID: 15553661
    [Abstract] [Full Text] [Related]

  • 24. Candesartan cilexetil in hypertension: effects of six weeks' treatment on haemodynamics, baroreceptor sensitivity and the renin-angiotensin-aldosterone system.
    Fridman KU, Wysocki M, Friberg PR, Andersson OK.
    Blood Press; 1999 Sep; 8(4):242-7. PubMed ID: 10697305
    [Abstract] [Full Text] [Related]

  • 25. [Change from ACE inhibitor, Ca-antagonist or beta-blocker to candesartan cilexetil: better efficacy and tolerance. SWITCH study (German study segment)].
    Baumgart P, Reismann J, Pohlmeyer H, Düsing R.
    Dtsch Med Wochenschr; 2001 May 11; 126(19):547-50. PubMed ID: 11402910
    [Abstract] [Full Text] [Related]

  • 26. Effects of candesartan cilexetil and enalapril on inflammatory markers of atherosclerosis in hypertensive patients with non-insulin-dependent diabetes mellitus.
    Rosei EA, Rizzoni D, Muiesan ML, Sleiman I, Salvetti M, Monteduro C, Porteri E, CENTRO (CandEsartaN on aTherosclerotic Risk factors) study investigators.
    J Hypertens; 2005 Feb 11; 23(2):435-44. PubMed ID: 15662233
    [Abstract] [Full Text] [Related]

  • 27. [Investigations of the antihypertensive long-term action of candesartan cilexetil in different dosages under the influence of therapy-free intervals].
    Weisser B, Gerwe M, Braun M, Funken C.
    Arzneimittelforschung; 2005 Feb 11; 55(9):505-13. PubMed ID: 16229114
    [Abstract] [Full Text] [Related]

  • 28. Candesartan cilexetil, a new generation angiotensin II antagonist, provides dose dependent antihypertensive effect.
    Elmfeldt D, George M, Hübner R, Olofsson B.
    J Hum Hypertens; 1997 Sep 11; 11 Suppl 2():S49-53. PubMed ID: 9331007
    [Abstract] [Full Text] [Related]

  • 29. Comparison of angiotensin II receptor blockers: impact of missed doses of candesartan cilexetil and losartan in systemic hypertension.
    Mancia G, Dell'Oro R, Turri C, Grassi G.
    Am J Cardiol; 1999 Nov 18; 84(10A):28S-34S. PubMed ID: 10588092
    [Abstract] [Full Text] [Related]

  • 30. Acute effects of candesartan cilexetil (the new angiotensin II antagonist) on systemic and renal haemodynamics in hypertensive patients.
    Fridman K, Andersson OK, Wysocki M, Friberg P, Sunzel M.
    Eur J Clin Pharmacol; 1998 Sep 18; 54(7):497-501. PubMed ID: 9832289
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Update on the clinical pharmacology of candesartan cilexetil.
    Gavras H.
    Am J Hypertens; 2000 Jan 18; 13(1 Pt 2):25S-30S. PubMed ID: 10678285
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Evaluation of candesartan cilexetil in black patients with systemic hypertension: the ABC Trial.
    Association of Black Cardiologists (ABC) Candesartan Study Group.
    Heart Dis; 2000 Jan 18; 2(6):392-9. PubMed ID: 11728289
    [Abstract] [Full Text] [Related]

  • 38. Candesartan cilexetil plus hydrochlorothiazide combination: a review of its use in hypertension.
    Melian EB, Jarvis B.
    Drugs; 2002 Jan 18; 62(5):787-816. PubMed ID: 11929332
    [Abstract] [Full Text] [Related]

  • 39. Candesartan cilexetil is not associated with cough in hypertensive patients with enalapril-induced cough. Multicentre Cough Study Group.
    Tanser PH, Campbell LM, Carranza J, Karrash J, Toutouzas P, Watts R.
    Am J Hypertens; 2000 Feb 18; 13(2):214-8. PubMed ID: 10701823
    [Abstract] [Full Text] [Related]

  • 40. Candesartan cilexetil in combination with low-dose hydrochlorothiazide is effective in severe hypertension.
    Oparil S.
    Am J Cardiol; 1999 Nov 18; 84(10A):35S-41S. PubMed ID: 10588093
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.